Jaap Verweij
Cancer Drug Development Forum

Last Updated On 2/19/2021 7:25:25 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
Company: Octimet
Recipient: You

Stock and Other Ownership Interests
Company: Octimet
Recipient: You

Honoraria
Company: Sanofi
Recipient: You
Company: Novartis
Recipient: You
Company: XBiotech
Recipient: You
Company: Octimet
Recipient: You
Company: Basilea
Recipient: You
Company: Genmab
Recipient: You
Company: InteRNA
Recipient: You
Company: CoBioRes NV
Recipient: You
Company: Helsinn Healthcare
Recipient: You
Company: NanoGhost
Recipient: You
Company: NBE Therapeutics
Recipient: You
Company: 4D Pharma
Recipient: You

Consulting or Advisory Role
Company: Sanofi
Recipient: You
Company: Sotio
Recipient: You
Company: Novartis
Recipient: You
Company: XBiotech
Recipient: You
Company: Basilea
Recipient: You
Company: Genmab
Recipient: You
Company: InteRNA
Recipient: You
Company: CoBioRes NV
Recipient: You
Company: NanoGhost
Recipient: You
Company: Helsinn Healthcare
Recipient: You
Company: 4D Pharma
Recipient: You
Company: NBE Therapeutics
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
No Relationships to Disclose

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Basilea
Recipient: You
Company: Sanofi
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose